Defense Health Agency Contracting Activity - DHACA

Description

The intent of the Peer Reviewed Cancer Research Program (PRCRP) Discovery Award is to support innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or methods. Studies supported by this award are expected to develop robust preliminary data that will lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. The Discovery Award is not intended to support a logical progression of an already established research project. The proposed research project should be novel and innovative. Innovative research may introduce a new paradigm, challenge existing paradigms, look at existing problems from new perspectives, or exhibit other uniquely creative qualities. Research that is an incremental advance upon published data is not considered innovative and will not be considered for funding under this award mechanism. All applications must address research in one or more of the required FY11 PRCRP Topic Areas: blood cancers, colorectal cancer, genetic cancer, kidney cancer, listeria vaccine for cancer, melanoma and other skin cancers, mesothelioma, pancreatic cancer, pediatric cancers, and radiation protection utilizing nanotechnology.

Who can apply

• Unrestricted

Contact

PA HELP and eReceipt HELP: 301-682-5507; help@cdmrp.org
help@cdmrp.org